Inventor · disambiguated record
Tseten Yeshi
Also filed as: YESHI TSETEN
3 granted patents·7 pending applications·26 citations·filing 2013–2022
64Inventor score
Top patents by PatentIndex Score
10 records- 0192US10415024B2Site-specific enzymes and methods of usePOSEIDA THERAPEUTICS INC·Filed 2013·Granted Sep 17, 2019·25 cites·8 claims
- 0278US10844361B2Site-specific enzymes and methods of usePOSEIDA THERAPEUTICS INC·Filed 2019·Granted Nov 24, 2020·1 cites·17 claims
- 0363US2021062170A1Site-specific enzymes and methods of usePOSEIDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0463US2023257737A1Compositions and methods for directing proteins to specific loci in the genomePOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0551US11473082B2Compositions and methods for directing proteins to specific loci in the genomePOSEIDA THERAPEUTICS INC·Filed 2016·Granted Oct 18, 2022·0 cites·28 claims
- 0648US2016046959A1Reproducible method for testis-mediated genetic modification (tgm) and sperm-mediated genetic modification (sgm)LANDEL CARLISLE P·Filed 2014·Application pending·0 cites
- 0742US2017112108A1Genetically modified non-human mammals having modified liver cells and/or tissue and methods of making sameHERA TESTING LABORATORIES INC·Filed 2016·Application pending·0 cites
- 0837US2021092942A1Novel immunodeficient rat for modeling human cancerHERA TESTING LABORATORIES INC·Filed 2018·Application pending·0 cites
- 0931US2017107541A1A method for directing proteins to specific loci in the genome and uses thereofPOSEIDA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1030US2017114149A1Methods and compositions for in vivo non-covalent linkingPOSEIDA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tseten Yeshi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →